These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27055583)

  • 21. Cutting-edge issues in autoimmune uveitis.
    Levy RA; de Andrade FA; Foeldvari I
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):214-23. PubMed ID: 21913066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posterior scleritis in children: clinical features and treatment.
    Cheung CM; Chee SP
    Ophthalmology; 2012 Jan; 119(1):59-65. PubMed ID: 22137553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual case of Behcet disease with posterior scleritis: A case report.
    Yanagida C; Usui Y; Sakai JI; Goto H
    Medicine (Baltimore); 2019 Aug; 98(35):e16886. PubMed ID: 31464918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and visual outcomes of Japanese patients with scleritis.
    Keino H; Watanabe T; Taki W; Nakashima C; Okada AA
    Br J Ophthalmol; 2010 Nov; 94(11):1459-63. PubMed ID: 20576778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of episcleritis and scleritis].
    Tappeiner C; Walscheid K; Heiligenhaus A
    Ophthalmologe; 2016 Sep; 113(9):797-810. PubMed ID: 27550224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tyranny of the anecdote: Waldenstrom's macroglobulinemia and scleritis.
    Rosenbaum JT; Becker MD
    Ocul Immunol Inflamm; 2000 Jun; 8(2):111-3. PubMed ID: 10980683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scleritis: presentations, disease associations and management.
    Sims J
    Postgrad Med J; 2012 Dec; 88(1046):713-8. PubMed ID: 22977282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Scleritis and episcleritis].
    Héron E; Bourcier T
    J Fr Ophtalmol; 2017 Oct; 40(8):681-695. PubMed ID: 28916114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necrotizing scleritis after ocular surgery. A clinicopathologic study.
    Sainz de la Maza M; Foster CS
    Ophthalmology; 1991 Nov; 98(11):1720-6. PubMed ID: 1839324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poststreptococcal syndrome presenting as posterior scleritis in a child.
    Hilkert SM; Koreishi AF; Pyatetsky D
    J AAPOS; 2017 Apr; 21(2):163-165. PubMed ID: 28007653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.
    McCluskey PJ; Watson PG; Lightman S; Haybittle J; Restori M; Branley M
    Ophthalmology; 1999 Dec; 106(12):2380-6. PubMed ID: 10599675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of the Sclera in Patients with Scleritis and Episcleritis using Anterior Segment Optical Coherence Tomography.
    Axmann S; Ebneter A; Zinkernagel MS
    Ocul Immunol Inflamm; 2016; 24(1):29-34. PubMed ID: 26259046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and ocular complications of patients with scleritis in Japanese.
    Tanaka R; Kaburaki T; Ohtomo K; Takamoto M; Komae K; Numaga J; Fujino Y; Aihara M
    Jpn J Ophthalmol; 2018 Jul; 62(4):517-524. PubMed ID: 29796754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
    Ragam A; Kolomeyer AM; Fang C; Xu Y; Chu DS
    Ocul Immunol Inflamm; 2014 Dec; 22(6):469-77. PubMed ID: 24354512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectious Scleritis: Pathophysiology, Diagnosis, and Management.
    Yu J; Syed ZA; Rapuano CJ
    Eye Contact Lens; 2021 Aug; 47(8):434-441. PubMed ID: 34224444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scleritis and systemic disease association in a community-based referral practice.
    Raiji VR; Palestine AG; Parver DL
    Am J Ophthalmol; 2009 Dec; 148(6):946-50. PubMed ID: 19837380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological evaluation of scleritis.
    Hankins M; Margo CE
    J Clin Pathol; 2019 May; 72(5):386-390. PubMed ID: 30723093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scleritis and systemic diseases: What should know the internist?].
    Bielefeld P; Saadoun D; Héron E; Abad S; Devilliers H; Deschasse C; Trad S; Sène D; Kaplanski G; Sève P
    Rev Med Interne; 2018 Sep; 39(9):711-720. PubMed ID: 29496270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.